Ernexa Therapeutics Inc.

Item 5.07 Submission of Matters to a Vote of Security Holders. On July 1, 2027, Ernexa Therapeutics Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on May 6, 2026, the record date for the Annual Meeting (the “Record Date”), There were 1,166,333 shares of our common stock issued and outstanding as of the Record Date, all of which are entitled to be voted at the annual meeting. At the Annual Meeting, a total of 619,741 shares of the Company’s common stock, equivalent to approximately 53.13% of the outstanding shares, were represented in person or by proxy at the Annual Meeting, constituting a quorum. The final voting results for the proposals submitted to a vote of the Company’s stockholders at the Annual Meeting are as follows: Proposal 1 : Each of the director nominees identified below were elected to the Board of Directors of the Company to hold office until the Company’s 2027 Annual Meeting of Stockholders or until their respective successors are elected and qualified, by the votes set forth below. Votes Votes Broker Director For Withheld Non-Votes ────────────────────────────────────────────────────── James 455,380 3,196 161,165 Bristol Peter 455,121 3,455 161,165 Cicala Sanjeev 442,564 16,012 161,165 Luther Elena 455,633 2,943 161,165 Ratner William 455,156 3,420 161,165 Wexler Proposal 2 : The Company’s stockholders ratified, by the votes set forth below, the appointment of Haskell & White LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year. Votes Votes Broker For Against Abstentions Non-Votes ──────────────────────────────────────────────────────── 590,236 29,010 495 — Proposal 3 : The Company’s stockholders approved the adoption of the 2026 Ernexa Therapeutics Inc. Omnibus Equity Incentive Plan by the votes set forth below. Votes Votes Broker For Against Abstentions Non-Votes ──────────────────────────────────────────────────────── 363,640 94,840 96 161,165 No other matters were considered or voted upon at the Annual Meeting.